S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Biden Executive Order 14017 Potentially Sending Lithium Stocks Skyrocketing (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
'The Sacrifice Zone': Myanmar bears cost of green energy
Can Etsy Continue to Thrive After the Pandemic?
Biden Executive Order 14017 Potentially Sending Lithium Stocks Skyrocketing (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Biden Executive Order 14017 Potentially Sending Lithium Stocks Skyrocketing (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
'The Sacrifice Zone': Myanmar bears cost of green energy
Can Etsy Continue to Thrive After the Pandemic?
Biden Executive Order 14017 Potentially Sending Lithium Stocks Skyrocketing (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Biden Executive Order 14017 Potentially Sending Lithium Stocks Skyrocketing (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
'The Sacrifice Zone': Myanmar bears cost of green energy
Can Etsy Continue to Thrive After the Pandemic?
Biden Executive Order 14017 Potentially Sending Lithium Stocks Skyrocketing (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Biden Executive Order 14017 Potentially Sending Lithium Stocks Skyrocketing (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
'The Sacrifice Zone': Myanmar bears cost of green energy
Can Etsy Continue to Thrive After the Pandemic?
Biden Executive Order 14017 Potentially Sending Lithium Stocks Skyrocketing (Ad)

Medical Properties Trust - MPW Stock Forecast, Price & News

$16.18
+0.30 (+1.89%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$15.99
$16.28
50-Day Range
$14.34
$18.58
52-Week Range
$14.10
$24.13
Volume
5.99 million shs
Average Volume
6.21 million shs
Market Capitalization
$9.71 billion
P/E Ratio
8.09
Dividend Yield
7.30%
Price Target
$19.64

Medical Properties Trust MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.55 Rating Score
Upside/​Downside
21.4% Upside
$19.64 Price Target
Short Interest
Healthy
7.15% of Shares Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.39
Upright™ Environmental Score
News Sentiment
0.99mentions of Medical Properties Trust in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
2.21%
From $1.81 to $1.85 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.17 out of 5 stars

Finance Sector

47th out of 885 stocks

Real Estate Investment Trusts Industry

3rd out of 197 stocks

MPW stock logo

About Medical Properties Trust (NYSE:MPW) Stock

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Medical Properties Trust Trading Up 1.9 %

Medical Properties Trust stock opened at $16.18 on Tuesday. The company has a current ratio of 1.87, a quick ratio of 1.64 and a debt-to-equity ratio of 1.14. Medical Properties Trust has a 12 month low of $14.10 and a 12 month high of $24.13. The stock's 50 day simple moving average is $16.03 and its two-hundred day simple moving average is $18.68. The firm has a market cap of $9.71 billion, a PE ratio of 8.09, a P/E/G ratio of 0.88 and a beta of 0.75.

Medical Properties Trust Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, July 14th. Stockholders of record on Thursday, June 16th were paid a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a dividend yield of 7.17%. The ex-dividend date was Wednesday, June 15th. Medical Properties Trust's payout ratio is 58.00%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. JPMorgan Chase & Co. lowered Medical Properties Trust from an "overweight" rating to a "neutral" rating and dropped their target price for the company from $24.00 to $18.00 in a research report on Wednesday, June 22nd. Truist Financial dropped their target price on Medical Properties Trust from $23.00 to $18.00 in a research report on Monday, July 11th. Barclays dropped their target price on Medical Properties Trust from $27.00 to $23.00 and set an "overweight" rating on the stock in a research report on Thursday, August 4th. Credit Suisse Group lowered Medical Properties Trust from an "outperform" rating to a "neutral" rating and dropped their target price for the company from $23.00 to $17.00 in a research report on Thursday, July 14th. Finally, KeyCorp dropped their target price on Medical Properties Trust from $23.00 to $18.00 and set an "overweight" rating on the stock in a research report on Thursday, July 7th. Seven equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.64.

Receive MPW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medical Properties Trust and its competitors with MarketBeat's FREE daily newsletter.

MPW Stock News Headlines

The Only Bear On Medical Properties Trust
5 REITs With A Dividend Yield Above 6%
Medical Properties Trust (NYSE:MPW) Shares Down 5%
Medical Properties Trust (NYSE:MPW) PT Lowered to $20.00
What 10 Analyst Ratings Have To Say About Medical Properties Trust
Where Medical Properties Trust Stands With Analysts
See More Headlines
Receive MPW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medical Properties Trust and its competitors with MarketBeat's FREE daily newsletter.

MPW Company Calendar

Last Earnings
4/28/2022
Ex-Dividend for 7/14 Dividend
6/15/2022
Dividend Payable
7/14/2022
Today
8/09/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
Sector
Finance
CUSIP
58463J30
Employees
112
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$19.64
High Stock Price Forecast
$26.00
Low Stock Price Forecast
$15.00
Forecasted Upside/Downside
+21.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.55
Research Coverage
11 Analysts

Profitability

Net Income
$656.02 million
Pretax Margin
76.87%

Debt

Sales & Book Value

Annual Sales
$1.54 billion
Cash Flow
$1.72 per share
Book Value
$14.16 per share

Miscellaneous

Free Float
592,839,000
Market Cap
$9.71 billion
Optionable
Optionable
Beta
0.75

Social Links















MPW Stock - Frequently Asked Questions

Should I buy or sell Medical Properties Trust stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Properties Trust in the last twelve months. There are currently 6 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MPW shares.
View MPW analyst ratings
or view top-rated stocks.

What is Medical Properties Trust's stock price forecast for 2022?

11 equities research analysts have issued 1 year price targets for Medical Properties Trust's stock. Their MPW share price forecasts range from $15.00 to $26.00. On average, they expect the company's stock price to reach $19.64 in the next twelve months. This suggests a possible upside of 21.4% from the stock's current price.
View analysts price targets for MPW
or view top-rated stocks among Wall Street analysts.

How has Medical Properties Trust's stock performed in 2022?

Medical Properties Trust's stock was trading at $23.63 at the beginning of 2022. Since then, MPW shares have decreased by 31.5% and is now trading at $16.18.
View the best growth stocks for 2022 here
.

When is Medical Properties Trust's next earnings date?

Medical Properties Trust is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our MPW earnings forecast
.

How were Medical Properties Trust's earnings last quarter?

Medical Properties Trust, Inc. (NYSE:MPW) issued its earnings results on Thursday, April, 28th. The real estate investment trust reported $1.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.47 by $0.58. The real estate investment trust earned $409.80 million during the quarter, compared to analysts' expectations of $413.31 million. Medical Properties Trust had a trailing twelve-month return on equity of 13.86% and a net margin of 74.46%. The firm's revenue was up 13.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.42 EPS.

How often does Medical Properties Trust pay dividends? What is the dividend yield for Medical Properties Trust?

Medical Properties Trust announced a quarterly dividend on Thursday, May 26th. Shareholders of record on Thursday, June 16th will be paid a dividend of $0.29 per share on Thursday, July 14th. This represents a $1.16 annualized dividend and a dividend yield of 7.17%. The ex-dividend date of this dividend is Wednesday, June 15th.
Read our dividend analysis for MPW
.

Is Medical Properties Trust a good dividend stock?

Medical Properties Trust (NYSE:MPW) pays an annual dividend of $1.16 per share and currently has a dividend yield of 7.30%. MPW has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 8 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 58.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MPW will have a dividend payout ratio of 62.70% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MPW.

What guidance has Medical Properties Trust issued on next quarter's earnings?

Medical Properties Trust updated its FY 2022 earnings guidance on Wednesday, August, 3rd. The company provided EPS guidance of $1.78-$1.82 for the period. The company issued revenue guidance of -.

What other stocks do shareholders of Medical Properties Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Properties Trust investors own include AT&T (T), Verizon Communications (VZ), Energy Transfer (ET), Enterprise Products Partners (EPD), Omega Healthcare Investors (OHI), New Residential Investment (NRZ), Cisco Systems (CSCO), Pfizer (PFE), AbbVie (ABBV) and Intel (INTC).

What is Medical Properties Trust's stock symbol?

Medical Properties Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MPW."

Who are Medical Properties Trust's major shareholders?

Medical Properties Trust's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Sarasin & Partners LLP (1.10%), Sumitomo Mitsui Trust Holdings Inc. (0.67%), Border to Coast Pensions Partnership Ltd (0.36%), Presima Inc. (0.21%), Asset Management One Co. Ltd. (0.20%) and Victory Capital Management Inc. (0.17%). Insiders that own company stock include Edward K Aldag Jr, Emmett E Mclean, G Steven Dawson, Holzgrefe Richard, James Kevin Hanna, Michael G Stewart and R Steven Hamner.
View institutional ownership trends
.

How do I buy shares of Medical Properties Trust?

Shares of MPW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medical Properties Trust's stock price today?

One share of MPW stock can currently be purchased for approximately $16.18.

How much money does Medical Properties Trust make?

Medical Properties Trust (NYSE:MPW) has a market capitalization of $9.71 billion and generates $1.54 billion in revenue each year. The real estate investment trust earns $656.02 million in net income (profit) each year or $2.00 on an earnings per share basis.

How many employees does Medical Properties Trust have?

Medical Properties Trust employs 112 workers across the globe.

How can I contact Medical Properties Trust?

Medical Properties Trust's mailing address is 1000 URBAN CENTER DRIVE SUITE 501, BIRMINGHAM AL, 35242. The official website for the company is www.medicalpropertiestrust.com. The real estate investment trust can be reached via phone at (205) 969-3755, via email at tberryman@medicalpropertiestrust.com, or via fax at 205-969-3756.

This page (NYSE:MPW) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.